Standout Papers

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with An... 1998 2026 2007 2016 2.1k
  1. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (2002)
    Mark E. Dudley, John R. Wunderlich et al. Science
  2. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes (2006)
    Richard A. Morgan, Mark E. Dudley et al. Science
  3. Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2 (2010)
    Richard A. Morgan, James C. Yang et al. Molecular Therapy
  4. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy (2011)
    Steven A. Rosenberg, James Chih‐Hsin Yang et al. Clinical Cancer Research
  5. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma (1998)
    Steven A. Rosenberg, James Chih‐Hsin Yang et al. Nature Medicine
  6. Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired (2009)
    Mojgan Ahmadzadeh, Laura A. Johnson et al. Blood
  7. Adoptive immunotherapy for cancer: harnessing the T cell response (2012)
    Nicholas P. Restifo, Mark E. Dudley et al. Nature reviews. Immunology
  8. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer (2014)
    Eric Tran, Simon Turcotte et al. Science
  9. Adoptive cell transfer: a clinical path to effective cancer immunotherapy (2008)
    Steven A. Rosenberg, Nicholas P. Restifo et al. Nature reviews. Cancer
  10. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells (2011)
    James N. Kochenderfer, Mark E. Dudley et al. Blood
  11. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 (2010)
    James N. Kochenderfer, Wyndham H. Wilson et al. Blood
  12. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens (2008)
    Mark E. Dudley, James Chih‐Hsin Yang et al. Journal of Clinical Oncology
  13. T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis (2010)
    Maria R. Parkhurst, James C. Yang et al. Molecular Therapy
  14. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors (2014)
    Alena Gros, Paul F. Robbins et al. Journal of Clinical Investigation
  15. A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response (2014)
    Paul F. Robbins, Sadik H. Kassim et al. Clinical Cancer Research
  16. Adoptive-cell-transfer therapy for the treatment of patients with cancer (2003)
    Mark E. Dudley, Steven A. Rosenberg Nature reviews. Cancer
  17. Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients (2003)
    Mark E. Dudley, John R. Wunderlich et al. Journal of Immunotherapy
  18. Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells (2015)
    Sanja Stevanović, Lindsey M. Draper et al. Journal of Clinical Oncology

Immediate Impact

18 by Nobel laureates 52 from Science/Nature 249 standout
Sub-graph 1 of 13

Citing Papers

Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
9 intermediate papers

Works of Mark E. Dudley being referenced

Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
2014
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
and 11 more

Author Peers

Author Last Decade Papers Cites
Mark E. Dudley 22980 19904 5558 6685 113 28.7k
James C. Yang 14905 11845 4050 5634 135 20.4k
Richard M. Sherry 18219 13589 3741 6035 96 24.6k
Paul F. Robbins 19940 21066 4092 8818 178 28.5k
John R. Wunderlich 15486 14596 3366 4734 121 20.7k
Richard A. Morgan 13054 7938 6419 6922 120 18.3k
Gianpietro Dotti 18657 10206 6294 7479 284 25.6k
Renier J. Brentjens 14711 6602 4319 5037 194 17.7k
Udai S. Kammula 13715 10107 2654 4181 89 17.8k
Michael Kalos 11484 5916 4049 4825 94 15.2k
David L. Porter 15738 6177 4856 4727 205 18.9k

All Works

Loading papers...

Rankless by CCL
2026